Related Experiment Videos
[Acute plasma cell leukemia. Clinical course during high-dose melphalan therapy]
S Handt1, S Handt, W M Glöckner
1Medizinische Klinik II, Technischen Hochschule Aachen.
Deutsche Medizinische Wochenschrift (1946)
|March 26, 1993
Summary
High-dose melphalan induced remission in a patient with plasma cell leukemia and extramedullary disease. Despite initial success, the patient experienced recurrences and ultimately succumbed to complications.
Area of Science:
- Hematology
- Oncology
Background:
- Plasma cell leukemia is a rare and aggressive hematologic malignancy.
- Extramedullary involvement and hepatosplenomegaly are common in advanced disease.